Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation
- PMID: 9525976
- PMCID: PMC508711
- DOI: 10.1172/JCI774
Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation
Abstract
Increased nitric oxide (NO) production may contribute to the pathological changes featuring in some inflammatory diseases, but the role of NO in chronic viral hepatitis is still unknown. We compared the inducible NO synthase (NOS2) expression in the liver of patients with chronic viral hepatitis with that of both nonviral liver disease and histologically normal liver. NOS2 expression was assessed by immunohistochemical and in situ hybridization studies of liver biopsy sections. An intense hepatocellular NOS2 reactivity was detected in chronic viral hepatitis, whereas it was weakly or not observed in nonviral liver disease or normal liver, respectively. In addition, we determined whether the hepatitis B virus (HBV) might regulate the synthesis of this enzyme. NOS2 mRNA and protein levels as well as enzyme activity were assessed in cytokine-stimulated HBV-transfected and untransfected hepatoma cells. Transfection with either HBV genome or HBV X gene resulted in induction of NOS2 mRNA expression, and the maximal induction of this transcript and NO production was observed in cytokine-stimulated HBV-transfected cells. These results indicate that hepatotropic viral infections are able to upregulate the NOS2 gene expression in human hepatocytes, suggesting that NO may mediate important pathogenic events in the course of chronic viral hepatitis.
Similar articles
-
IL-4 and interferon gamma regulate expression of inducible nitric oxide synthase in chronic lymphocytic leukemia cells.Leukemia. 2003 Feb;17(2):442-50. doi: 10.1038/sj.leu.2402783. Leukemia. 2003. PMID: 12592345
-
The role of inducible nitric oxide synthase in a murine acute hepatitis B virus (HBV) infection model induced by hydrodynamics-based in vivo transfection of HBV-DNA.J Hepatol. 2003 Nov;39(5):834-42. doi: 10.1016/s0168-8278(03)00389-1. J Hepatol. 2003. PMID: 14568268
-
Heat shock response inhibits cytokine-inducible nitric oxide synthase expression in rat hepatocytes.Hepatology. 1996 Nov;24(5):1238-45. doi: 10.1002/hep.510240542. Hepatology. 1996. PMID: 8903404
-
Regulation of the expression of the inflammatory nitric oxide synthase (NOS2) by cyclic AMP.FASEB J. 1999 Dec;13(15):2125-37. doi: 10.1096/fasebj.13.15.2125. FASEB J. 1999. PMID: 10593859 Review.
-
Inducible nitric oxide synthase in the liver: regulation and function.Biochemistry (Mosc). 1998 Jul;63(7):766-81. Biochemistry (Mosc). 1998. PMID: 9721329 Review.
Cited by
-
Angiogenesis: a phenomenon which aggravates chronic liver disease progression.Hepatol Int. 2013 Mar;7(1):4-12. doi: 10.1007/s12072-012-9391-2. Epub 2012 Jul 26. Hepatol Int. 2013. PMID: 26201617
-
S-nitrosoglutathione reductase deficiency increases mutagenesis from alkylation in mouse liver.Carcinogenesis. 2013 May;34(5):984-9. doi: 10.1093/carcin/bgt031. Epub 2013 Jan 25. Carcinogenesis. 2013. PMID: 23354311 Free PMC article.
-
Nitric oxide and virus infection.Immunology. 2000 Nov;101(3):300-8. doi: 10.1046/j.1365-2567.2000.00142.x. Immunology. 2000. PMID: 11106932 Free PMC article. Review.
-
Nitrative and oxidative DNA damage as potential survival biomarkers for nasopharyngeal carcinoma.Med Oncol. 2011 Mar;28(1):377-84. doi: 10.1007/s12032-010-9434-2. Epub 2010 Mar 26. Med Oncol. 2011. PMID: 20339958 Clinical Trial.
-
Inducible nitric oxide synthase: Regulation, structure, and inhibition.Med Res Rev. 2020 Jan;40(1):158-189. doi: 10.1002/med.21599. Epub 2019 Jun 13. Med Res Rev. 2020. PMID: 31192483 Free PMC article. Review.